美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alterity Therapeutics Limited

0.0101

0.0000

成交量：- -

成交额：- -

市值：1.10亿

市盈率：-4.11

高：0.0101

开：0.0101

低：0.0101

收：0.0101

52周最高：0.0139

52周最低：0.0030

股本：108.75亿

流通股本：85.96亿

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.0025

每股收益(LYR):-0.0035

净资产收益率：-47.02%

总资产收益率：-32.54%

市净率：2.88

市盈率(LYR):-2.89

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Alterity Therapeutics Limited

交易所：

PINK LIMITED

成立时间：

1997

员工人数：

9

公司地址：

350 Collins Street,Suite 4,Level 14,Melbourne,Victoria,Australia

官网：

http://www.pranabio.com

邮编：

3000

电话：

传真：

61 3 9349 4906

简介：

Prana Biotechnology is developing first-in-class therapies to treat neurodegenerative disease.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PRNAF/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRNAF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRNAF\",,,,,undefined,":{"symbol":"PRNAF","market":"US","secType":"STK","nameCN":"Alterity Therapeutics Limited","latestPrice":0.0101,"timestamp":1772658000000,"preClose":0.0101,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":8596486975,"shares":10875416329,"eps":-0.002455,"marketStatus":"未开盘","change":0,"latestTime":"03-04 16:00:00 EST 延时","open":0.0101,"high":0.0101,"low":0.0101,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.002455,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772701200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":0.0101,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRNAF\",,,,,undefined,":{"symbol":"PRNAF","floatShares":8596486975,"roa":"-32.54%","roe":"-47.02%","lyrEps":-0.003496,"shares":10875416329,"dividePrice":0,"high":0.0101,"amplitude":0,"preClose":0.0101,"low":0.0101,"week52Low":0.003,"pbRate":"2.88","psRate":"23.57","week52High":0.0139,"institutionHeld":0,"latestPrice":0.0101,"eps":-0.002455,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.002455,"open":0.0101,"prevYearClose":0.00625,"prevWeekClose":0.0101,"prevMonthClose":0.0101,"prevQuarterClose":0.0063,"fiveDayClose":0.0101,"twentyDayClose":0.0097,"sixtyDayClose":0.0063},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRNAF\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRNAF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRNAF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1765947600000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":2383747,"yearFounded":1997,"employeeNum":9,"address":"350 Collins Street,Suite 4,Level 14,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9349 4906","officeFax":"61 3 9349 4906"},"stockCompanyDetail":{"websiteUrl":"http://www.pranabio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0708},{"period":"3month","weight":215.5},{"period":"6month","weight":-0.3537},{"period":"1year","weight":-0.2268},{"period":"ytd","weight":0.031}],"description":"Prana Biotechnology is developing first-in-class therapies to treat neurodegenerative disease.","exchange":"PINK LIMITED","name":"Alterity Therapeutics Limited","nameEN":"Alterity Therapeutics Limited"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PRNAF\",market:\"US\",,,undefined,":null}}